NEWS

Select Month & Year

30 Mar 2018

In view of recent developments in the renewal process of the active substance chlorpropham under Regulation (EU) 1107/2009, we hereby give a short summary of the current status.

Read More

24 Nov 2017

CARY, N.C. (21 November 2017) – Arysta LifeScience, a Platform Specialty Products Company (NYSE: PAH), recently named Hildo Brilleman as the company’s chief executive officer of its Europe, Middle East & Africa (EMEA) region, effective January 1, 2018.

Read More

10 Nov 2017

CARY, N.C. and JOHNSTON, IOWA (7 November 2017) – Arysta LifeScience, a Platform Specialty Products Company (NYSE:PAH), recently announced that it has initiated a long-term global strategic collaboration with DuPont.

Read More

03 Jul 2017

Amsterdam—July 4, 2017— Following the announcement of Arysta LifeScience to build for 2018 a new marketing and sales organization in the Netherlands, dated 13th June 2017, the Company announced today the appointment of Nico Stuijt as Country Manager for Arysta LifeScience Netherlands, effective 21st August.

 

Read More

Pages